Arrhythmias & electrophysiology

Integrated care management for older multimorbid patients with atrial fibrillation: Rationale, design and baseline characteristics for the atrial fibrillation integrated approach in frail, multimorbid and polymedicated older people (AFFIRMO) trial

Am Heart JPublished European multicenter, open-label, cluster-randomized study

Study context

Population
Patients with atrial fibrillation (AF) ≥65 years with ≥1 concomitant chronic condition(s), across 6 European countries (Bulgaria, Denmark, Italy, Romania, Serbia, and Spain)patients with AF enrolled
Participants
1,260 patients
Planned comparison
mobile-health integrated care approach based on the ABC pathway combined with a multidimensional Comprehensive Geriatric Assessment (CGA)

No results yet. This paper sets out the design of a trial; its results are to come.

Baseline

Baseline characteristics

Mean age (SD) years
74 [SD 6]
Female
44.4%
Median (IQR) CHA2DS2-VASc score
4 (3-5)
Median (IQR) HAS-BLED score
1 (1-2)
Hypertension
992 (78.7%)
Diabetes mellitus
369 (29.3%)
Prefrail
507 (40.5%)
Frail
171 (13.7%)
Oral anticoagulants (OACs) prescribed
1,225 (97.2%)
Receiving NOACs
1,149 (91.2%)

Study conduct

  • Follow-up is ongoing and planned to be completed in January 2026.

Original publication

Integrated care management for older multimorbid patients with atrial fibrillation: Rationale, design and baseline characteristics for the atrial fibrillation integrated approach in frail, multimorbid and polymedicated older people (AFFIRMO) trial. Am Heart J. Published 22 January 2026. doi:10.1016/j.ahj.2026.107356

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.